Javascript must be enabled to continue!
S100A6: molecular function and biomarker role
View through CrossRef
AbstractS100A6 (also called calcyclin) is a Ca2+-binding protein that belongs to the S100 protein family. S100A6 has many functions related to the cytoskeleton, cell stress, proliferation, and differentiation. S100A6 also has many interacting proteins that are distributed in the cytoplasm, nucleus, cell membrane, and outside the cell. Almost all these proteins interact with S100A6 in a Ca2+-dependent manner, and some also have specific motifs responsible for binding to S100A6. The expression of S100A6 is regulated by several transcription factors (such as c-Myc, P53, NF-κB, USF, Nrf2, etc.). The expression level depends on the specific cell type and the transcription factors activated in specific physical and chemical environments, and is also related to histone acetylation, DNA methylation, and other epigenetic modifications. The differential expression of S100A6 in various diseases, and at different stages of those diseases, makes it a good biomarker for differential diagnosis and prognosis evaluation, as well as a potential therapeutic target. In this review, we mainly focus on the S100A6 ligand and its transcriptional regulation, molecular function (cytoskeleton, cell stress, cell differentiation), and role as a biomarker in human disease and stem cells.
Springer Science and Business Media LLC
Title: S100A6: molecular function and biomarker role
Description:
AbstractS100A6 (also called calcyclin) is a Ca2+-binding protein that belongs to the S100 protein family.
S100A6 has many functions related to the cytoskeleton, cell stress, proliferation, and differentiation.
S100A6 also has many interacting proteins that are distributed in the cytoplasm, nucleus, cell membrane, and outside the cell.
Almost all these proteins interact with S100A6 in a Ca2+-dependent manner, and some also have specific motifs responsible for binding to S100A6.
The expression of S100A6 is regulated by several transcription factors (such as c-Myc, P53, NF-κB, USF, Nrf2, etc.
).
The expression level depends on the specific cell type and the transcription factors activated in specific physical and chemical environments, and is also related to histone acetylation, DNA methylation, and other epigenetic modifications.
The differential expression of S100A6 in various diseases, and at different stages of those diseases, makes it a good biomarker for differential diagnosis and prognosis evaluation, as well as a potential therapeutic target.
In this review, we mainly focus on the S100A6 ligand and its transcriptional regulation, molecular function (cytoskeleton, cell stress, cell differentiation), and role as a biomarker in human disease and stem cells.
Related Results
Interaction of S100A6 Protein with the Four-Helical Cytokines
Interaction of S100A6 Protein with the Four-Helical Cytokines
S100 is a family of over 20 structurally homologous, but functionally diverse regulatory (calcium/zinc)-binding proteins of vertebrates. The involvement of S100 proteins in numerou...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Biomarkers for capturing disease pathology as molecular process hyperstructure
Biomarkers for capturing disease pathology as molecular process hyperstructure
Abstract
Background
Precision of drugs in clinical development but also of approved treatment sees limits, documented as attrit...
RESENSI BUKU PETUNJUK PRAKTIS APLIKASI BIOMARKER SEDERHANA_1051_NUR ZAIDATUL FIZA_L021201051
RESENSI BUKU PETUNJUK PRAKTIS APLIKASI BIOMARKER SEDERHANA_1051_NUR ZAIDATUL FIZA_L021201051
Ekotoksikologi merupakan ilmu yang membahas tentang efek toksik yang berasal dari bahan-bahan kimia yang menimbulkan toksik terhadap organisme baik pada tingkat ekosistem, komunita...
A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia
A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia
Abstract
The hallmark of Chronic Myeloid Leukemia (CML) is Philadelphia chromosome t(9:22), which leads to formation of BCR-ABL1 fusion oncogene. BCR-ABL1 induces g...
Biomarker Evaluation and Clinical Development
Biomarker Evaluation and Clinical Development
Most candidate biomarkers are never adopted into clinical practice. The likelihood that a biomarker with good predictive properties will be incorporated into urologic decisi...
Resensi Buku Petunjuk Praktis Aplikasi Biomarker Sederhana_1069
Resensi Buku Petunjuk Praktis Aplikasi Biomarker Sederhana_1069
Biomarker dapat diartikan sebagai suatu reaksi secara biologis dari organisme terhadap adanya bahan pencemar yang berada di lingkungannya. Biomarker ini dapat dideteksi melalui tin...
Biomarker Discovery in Emergency Care – A Suggested Development Pathway
Biomarker Discovery in Emergency Care – A Suggested Development Pathway
Abstract
Background: Biomarkers are widely used in medical diagnosis with rigorous pathways for the identification, development. However, there are no published pathways fo...

